Presentations

• Infectious Diseases Society of America (IDSA) - IDSA 2008 Annual Meeting

1. Adjuvanting of Fluzone® with JVRS-100 Enhances H1N1, H3N2, and B Influenza Specific Humoral Responses and Increases the Frequency of Multifunctional CD4+ and CD8+ T-cells [PDF 5.2MB]

• Federation of American Societies of Experimental Biology (FASEB) - Experimental Biology 2008
  Juvaris Posters (April 2008):

1. Immunotherapy of Acute Leukemia with Cationic Lipid DNA Complexes (JVRS-100)
   [PDF 700KB]
2. Adjuvanting of Fluzone® with JVRS-100 in Mice, Rabbits and Non-Human Primates Demonstrates Increased Immunogenicity and Dose-Sparing [PDF 777KB]
3. Inverse relationship between innate and acquired immune responsiveness in mice initially dosed with cationic lipid DNA complexes (JVRS-100) [PDF 738KB]

• Infectious Diseases Society of America (IDSA) - IDSA 2007 Annual Meeting
  Juvaris Posters (October 2007):

1. Adjuvanting of existing flu vaccines with Cationic Lipid DNA complexes (JuvImmune™) for cross-protection and dose sparing [PDF 779KB]
2. Minimal Interspecies Variability in the Innate Immune Response to Cationic Lipid DNA Complexes (JuvImmune™) [PDF 1.25MB]
3. Plasmacytoid Dendritic Cells Are Dispensable For Antiviral Immune Responses Following Cationic-Lipid-DNA-Complex (CLDC) Adjuvanted Influenza Vaccination [PDF 344KB]
4. In Vivo Immunogenicity of SIV Vaccine Candidates With and Without a New Immunomodulator in Rhesus Macaques [PDF 6.4MB]
5. Enhanced Immune Response To Vaccination With Woodchuck Hepatitis Virus (WHV) Surface Antigen (WHsAg) Using Cationic Liposome-DNA Complexes (CLDC) As Adjuvant [PDF 414KB]

^ back to top